年轻身体活跃男性的人体测量肥胖现象:身体组成和脂肪分布的作用
Agnieszka Wasiluk1, Jerzy Saczuk1, Ryszard Asienkiewicz2
1Department of Health Promotion, Faculty of Physical Education and Health in Biala, Podlaska, Jozef Pilsudski University of Physical Education in Warsaw, 00-968 Warsaw, Poland.
Life (Basel, Switzerland)
|December 30, 2025
概括
身体质量指数 (BMI) 不足以评估活跃的年轻男性的健康状况. 腰围和腰比是身体脂肪和代谢风险的更好指标.
科学领域:
- 人体生理学 人体生理学
- 肥胖问题研究研究
- 运动医学 运动医学
背景情况:
- 身体质量指数 (BMI) 在区分脂肪和瘦肉量方面的局限性.
- 需要在活跃的年轻成年人中进行更好的肥胖评估.
- 专注于肥胖现象和身体组成.
研究的目的:
- 在男性大学生中评估肥胖现象.
- 检查表型,肌肉质量和脂肪分布之间的关联.
- 评估身体脂肪百分比 (%BF) 的预测因素.
主要方法:
- 174名男性大学生接受了人体测量测量 (BMI,WC,WHR) 和BIA.
- 基于BMI,%BF,WC和WHR的表型分类.
- 统计分析包括ANOVA和多重线性回归.
主要成果:
- MHNW表型是最常见的 (66.7%).
- BMI与%BF的相关性很差;WC和WHR是强有力的预测指标.
- 在某些表型中,较高的瘦身量与有利的脂肪分布有关.
结论:
- 单独的BMI不足以评估活跃年轻人的代谢风险.
- 在预测身体脂肪方面,WC和WHR优于BMI.
- 瘦肉量和脂肪分布的测量提高了对代谢和心血管疾病的风险识别.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
211
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
211
Drug Dosing: Obese Patients
189
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
189
Signs of Puberty
1.3K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.3K
Hypodermis
7.2K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
7.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
149
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
149


